In the cases provided for in
Article L. 1241-5,the Minister for Research may suspend or prohibit implementation of the protocol under the conditions described in
Articles R. 1232-18and
R. 1232-22. The decision to suspend or prohibit is communicated to the Director General of the Agence de la biomédecine.

